Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist
暂无分享,去创建一个
S. Swan | S. Murray | T. Marbury | B. Peng | P. Lebowitz | B. Johnson | J. Bauman | L. Adams | L. Kirby | J. Antal | M. Gutierrez | Brendan Johnson